Mediwound Net Worth

Mediwound Net Worth Analysis

Mediwound Target Price Consensus

Mediwound Target Price Projection

Mediwound's current and average target prices are 21.00 and 30.00, respectively. The current price of Mediwound is the price at which Mediwound is currently trading. On the other hand, Mediwound's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Mediwound and the information provided on this page.

Know Mediwound's Top Institutional Investors

Note, although Mediwound's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Mediwound's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 221.45 M.

Project Mediwound's profitablity

The company has Profit Margin (PM) of (1.1) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.32) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.32.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Mediwound's management efficiency

Mediwound has return on total asset (ROA) of (0.1988) % which means that it has lost $0.1988 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7792) %, meaning that it created substantial loss on money invested by shareholders. Mediwound's management efficiency ratios could be used to measure how well Mediwound manages its routine affairs as well as how well it operates its assets and liabilities. As of July 24, 2025, Return On Tangible Assets is expected to decline to -0.43. In addition to that, Return On Capital Employed is expected to decline to -0.43. At present, Mediwound's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Asset Turnover is expected to grow to 0.29, whereas Non Currrent Assets Other are forecasted to decline to about 310.2 K.

Mediwound Corporate Filings

Mediwound time-series forecasting models is one of many Mediwound's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mediwound's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Mediwound Earnings Estimation Breakdown

The calculation of Mediwound's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Mediwound is estimated to be -0.492 with the future projection ranging from a low of -0.58 to a high of -0.3225. Please be aware that this consensus of annual earnings estimates for Mediwound is based on EPS before non-recurring items and includes expenses related to employee stock options.

Mediwound Earnings Projection Consensus

Mediwound Earnings per Share Projection vs Actual

Actual Earning per Share of Mediwound refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Mediwound predict the company's earnings will be in the future. The higher the earnings per share of Mediwound, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Mediwound Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Mediwound, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Mediwound should always be considered in relation to other companies to make a more educated investment decision.

Mediwound Quarterly Analyst Estimates and Surprise Metrics

Mediwound Corporate Management

When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:

How To Invest In Mediwound Details

Is Mediwound Stock a good investment? Details

What is Mediwound's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details